All In MedTech

Regulatory pathways

What is a 510(k)? FDA premarket notification and substantial equivalence explained

What is a 510(k)? How FDA premarket notification works, what substantial equivalence and a predicate device mean, and how to look up 510(k) clearances.

By the All In MedTech editorial team · Published November 19, 2026 · 6 min read

A 510(k) is a premarket notification that a device maker sends to FDA to show that a new device is substantially equivalent to a device already legally on the market, called the predicate. If FDA agrees, it issues an order that clears the device for sale. It is the most common route to the US market for devices that need premarket review.

The name comes from section 510(k) of the Federal Food, Drug, and Cosmetic Act. The detailed rules are in 21 CFR Part 807, subpart E. This post explains when a 510(k) is needed, what substantial equivalence means, what goes into a submission, and how to read the public record.

When a 510(k) is required

Under 21 CFR 807.81, a firm that must register with FDA submits a premarket notification at least 90 days before it begins commercial distribution of a device in these situations:

  • The device is being introduced for the first time and is not exempt, not subject to PMA, and not going through De Novo.
  • An already marketed device is about to be significantly changed or modified in design, components, method of manufacture or intended use. The regulation describes this as a change that could significantly affect safety or effectiveness, or a major change in intended use.

FDA's 510(k) overview lists who typically submits: finished device manufacturers, specification developers, remanufacturers, reprocessors of single-use devices, and makers of components sold directly to end users.

When it is not required

  • Exempt devices. Many Class I and some Class II device types are exempt by regulation. The exemption has limits, set out in the ".9" section of each classification part (for example, 21 CFR 870.9 for cardiovascular devices). A device with a different intended use or a different fundamental technology than others of its type can lose the exemption.
  • Preamendment devices. Devices legally marketed before May 28, 1976, the date of the Medical Device Amendments, and not significantly changed are grandfathered.
  • Class III devices generally need a PMA instead, and novel devices with no predicate go through De Novo.

What substantial equivalence means

Substantial equivalence is the heart of the 510(k). Under 21 CFR 807.100(b), FDA finds a device substantially equivalent when it has the same intended use as the predicate and either:

  1. has the same technological characteristics, or
  2. has different technological characteristics, but the data show it is as safe and effective as a legally marketed device and it does not raise different questions of safety and effectiveness than the predicate.

Two points often confuse newcomers.

  • Equivalent is not identical. FDA says plainly that the new device and predicate do not need to be identical. A new material, a software update or a different energy source can still be substantially equivalent if testing shows no new questions are raised.
  • Intended use and indications for use are different things. Intended use is the general purpose of the device. Indications for use describe the disease, condition or population. A narrower or slightly different indication can still share the predicate's intended use, but a change that alters the general purpose usually cannot.

What a predicate device is

A predicate is a legally marketed device that is not subject to PMA. FDA's guidance recognizes three main kinds:

  • a preamendment device marketed before May 28, 1976,
  • a device reclassified from Class III to Class II or I, including through a granted De Novo, or
  • a device already found substantially equivalent through a 510(k).

A device removed from the market at FDA's initiative, or found by a court to be adulterated or misbranded, cannot serve as a predicate. Because cleared devices become predicates for later devices, a device's lineage can often be traced back through a chain of earlier 510(k)s.

What goes into a 510(k)

The required elements are listed in 21 CFR 807.87. In practice a submission typically includes:

  1. Device name, classification and product code.
  2. Indications for use and proposed labeling.
  3. A comparison table against the predicate covering intended use, design, materials, energy source and other features.
  4. Performance data, which can include bench testing, biocompatibility, sterilization and shelf life, electrical safety and electromagnetic compatibility, software documentation and cybersecurity information, and clinical data where needed.
  5. A 510(k) summary or a 510(k) statement (21 CFR 807.92 and 807.93).

Since October 1, 2023, FDA has required most 510(k)s to be submitted electronically using its eSTAR template.

Types of 510(k)

  • Traditional 510(k): the standard full submission.
  • Special 510(k): for certain changes to the submitter's own cleared device, where well-established methods can evaluate the change.
  • Abbreviated 510(k): relies on FDA guidance, special controls or recognized consensus standards to support equivalence.

FDA also runs a Safety and Performance Based Pathway for some well-understood device types, where meeting FDA-identified performance criteria can support equivalence, and a Third Party Review Program in which accredited organizations review eligible 510(k)s.

What happens after submission

FDA first checks the submission for completeness, then carries out a substantive review. Reviewers often send an "additional information" request, which pauses the review until the sponsor responds. The outcome is one of two orders:

  • Substantially equivalent (SE): the device is cleared and can be marketed immediately. FDA does not usually inspect the facility before clearance, but quality system inspections can follow at any time.
  • Not substantially equivalent (NSE): the device cannot be marketed through this 510(k). Options include resubmitting with new data, a De Novo request, a reclassification petition or a PMA.

Review time goals are negotiated under the Medical Device User Fee Amendments and change between agreements, so check FDA's MDUFA page for the current goals and user fees rather than relying on an old figure.

Cleared, not approved

The precise word for a 510(k) outcome is cleared. "FDA approved" applies to devices that went through PMA. Marketing materials that call a 510(k) device "FDA approved" are using the wrong term, and the difference matters to buyers and investors: clearance is a finding of equivalence to a predicate, not an independent finding of safety and effectiveness. For the full comparison, see 510(k) vs De Novo vs PMA.

Reading the public 510(k) record

FDA publishes every 510(k) decision in its 510(k) database. Each record shows the K number (for example K followed by six digits), applicant, device name, product code, decision date and, usually, a 510(k) summary describing the device, the predicate it was compared to and the testing performed. The summary is the most useful document for understanding what evidence supported the clearance.

A few habits help when reading records:

  • Check the product code. It tells you the classification regulation and class, and lets you compare a device with its competitors. See FDA device classes and product codes.
  • Follow the predicate. The summary names the predicate K number, which you can look up in turn.
  • Look at the decision date, not only the receipt date. The gap between them is the total time the submission took, including any pauses for additional information.
  • Pair clearance data with safety data. A clearance says nothing about how the device has performed since launch. Adverse event reports in MAUDE and recall history fill that gap.

Changes after clearance

A cleared device is not frozen. Manufacturers make changes all the time, and the question each time is whether the change could significantly affect safety or effectiveness or is a major change in intended use. If so, a new 510(k) is needed. FDA has published guidance on deciding when to submit a 510(k) for a change to an existing device, including a separate guidance for software changes. Changes that do not need a new submission still have to be documented in the manufacturer's quality system.

Frequently asked questions

What does 510(k) stand for?
It refers to section 510(k) of the Federal Food, Drug, and Cosmetic Act, which requires a premarket notification to FDA before certain devices are marketed.
What is a predicate device?
A predicate is a legally marketed device, not subject to PMA, that a new device is compared to in order to show substantial equivalence.
Does a 510(k) require clinical trials?
Not usually. Most 510(k)s rely on bench, biocompatibility and other performance testing, but FDA can ask for clinical data when differences from the predicate need it.
Can I market a device while the 510(k) is under review?
No. FDA states that a submitter may not market the device until it receives the order finding it substantially equivalent.

For information only, not medical, legal or investment advice. Facts about FDA, CMS and SEC rules are current as of the publication date; check the linked official source for changes.

Keep reading